Stock listing
476830 Stock Price, News, Filings & Events — Rznomics Inc.
Selected listing: 476830 · KRX · KRW · KR
This page tracks Rznomics Inc.'s 476830:KRX listing on KRX in KRW for KR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 476830:KRX. 476830:KRX is the stock-level entry point for investors researching Rznomics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Rznomics Inc. is a publicly traded company on the Korean market under the ticker 476830. The company has a market capitalization of approximately 750.7 million. Rznomics focuses on innovative solutions and technologies within its industry, aiming to drive growth and enhance value for its stakeholders.

- Ticker
- 476830:KRX
- Asset type
- Stock
- Market cap
- $539.3M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW
Rznomics Inc. 476830:KRX stock context
This page tracks Rznomics Inc.'s 476830:KRX listing on KRX in KRW for KR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 476830:KRX. 476830:KRX is the stock-level entry point for investors researching Rznomics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Rznomics Inc. is a publicly traded company on the Korean market under the ticker 476830. The company has a market capitalization of approximately 750.7 million. Rznomics focuses on innovative solutions and technologies within its industry, aiming to drive growth and enhance value for its stakeholders.
Latest news from Rznomics Inc.
Rznomics Reports Major Advances in High-Efficiency Circular RNA Production in Nucleic Acids Research
September 7, 2026
Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics
August 23, 2026
Rznomics Announces U.S. FDA Regenerative Medicine Advanced Therapy Designation Granted to 'RZ-001' for Hepatocellular Carcinoma
May 8, 2026
Rznomics Reports Interim Clinical Data for RZ-001 in Hepatocellular Carcinoma at AACR 2026 Demonstrating Encouraging Efficacy and Favorab...
April 20, 2026
Research Rznomics Inc.
Rznomics Inc. investor report
Review AI stock analysis and investor report context for 476830:KRX.
Rznomics Inc. company profile
View the public company page for Rznomics Inc. on 6ix.
Rznomics Inc. news
Read company news and market updates connected to Rznomics Inc..
Rznomics Inc. investor events
Find investor webinars, events, and replay context for Rznomics Inc..